FDA Inspection
Malladi Drugs & Pharmaceuticals Ltd.Malladi Drugs & Pharmaceuticals Ltd. – FDA Inspection, Aug 4, 2017
Record Details
This FDA Inspection record concerns Malladi Drugs & Pharmaceuticals Ltd., with an inspection on August 4, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 4fa99313-3ee2-4876-bc4d-03a16fca7105
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1022300
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Malladi Drugs & Pharmaceuticals Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 3, 2026 | Not classified | Office of Inspections and Investigations | |
| January 31, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 9, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 19, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Malladi Drugs & Pharmaceuticals Ltd.
- FDA Inspection 1331272 - 2026-07-03
- FDA Inspection 1119575 - 2020-01-31
- FDA Inspection 1070896 - 2018-10-09
- FDA Inspection 910002 - 2014-12-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.